Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,784 | -5,528 | -4,064 | -865 | -1,864 |
| Depreciation Amortization | 6,015 | 4,085 | 1,927 | 3,845 | 2,901 |
| Income taxes - deferred | N/A | -96 | -1,354 | -1,584 | 0 |
| Accounts receivable | 918 | -993 | 149 | 196 | 1,000 |
| Accounts payable and accrued liabilities | -442 | 1,798 | 1,346 | -918 | -786 |
| Other Working Capital | -990 | 2,623 | 4,149 | -3,811 | -1,646 |
| Other Operating Activity | 574 | -164 | -1,705 | 4,194 | 2,391 |
| Operating Cash Flow | $291 | $1,725 | $448 | $1,057 | $1,996 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -891 | -634 | -493 | -878 | -677 |
| Net Acquisitions | -52,254 | -52,254 | -51,683 | N/A | N/A |
| Other Investing Activity | -24 | -24 | -13 | -39 | -39 |
| Investing Cash Flow | $-53,169 | $-52,912 | $-52,189 | $-917 | $-716 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 70,800 | 68,500 | 67,000 | 2,750 | 2,250 |
| Debt Repayment | -19,947 | -17,247 | -14,047 | -4,702 | -3,502 |
| Common Stock Issued | 4,521 | 1,380 | 219 | 160 | -101 |
| Other Financing Activity | -1,967 | -1,928 | -1,928 | 0 | 0 |
| Financing Cash Flow | $53,407 | $50,705 | $51,244 | $-1,792 | $-1,353 |
| Exchange Rate Effect | 399 | 373 | 755 | 1,789 | 313 |
| Beginning Cash Position | 5,733 | 5,733 | 5,733 | 5,596 | 5,596 |
| End Cash Position | 6,661 | 5,624 | 5,991 | 5,733 | 5,836 |
| Net Cash Flow | $928 | $-109 | $258 | $137 | $240 |
| Free Cash Flow | |||||
| Operating Cash Flow | 291 | 1,725 | 448 | 1,057 | 1,996 |
| Capital Expenditure | -891 | -634 | -493 | -890 | -677 |
| Free Cash Flow | -600 | 1,091 | -45 | 167 | 1,319 |